GlassScriptPhysician profile
Robert Craig Gallagher
NPI 1801894829
$22,895.94
in general payments reported to CMS, 2019-2025
19 companies · $5,199 in 2025
The $5,199 reported for 2025 was more than what 83% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,692 · 2020: $1,884 · 2021: $583 · 2022: $7,983 · 2023: $439 · 2024: $116 · 2025: $5,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,150 · Food and Beverage: $1,604.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,149.51 |
| Food and Beverage | $1,604.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $12,270.83 | 2019-2023 | Da Vinci Surgical System |
| Edwards Lifesciences Corporation | $3,308.50 | 2019-2025 | Carpentier-Edwards Physio II Annuloplasty Ring |
| Atricure, INC. | $2,679.93 | 2020-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Atricure Cryoice Cryoablation System (Cryo2) |
| Abbott Laboratories | $1,965.23 | 2020-2023 | 2nd Gen Centrimag Primary Console |
| Abiomed | $1,838.83 | 2019-2025 | Impella |
| Biomerieux INC | $345.18 | 2022 | |
| Angiodynamics, INC. | $123.66 | 2021 | |
| Davol INC. | $78.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.84 | 2022-2025 | Lifevest |
| Takeda Pharmaceuticals U.S.A., INC. | $44.90 | 2019-2020 | |
| Bolton Medical INC | $34.22 | 2020 | |
| Getinge USA Sales, LLC | $30.30 | 2023 | Vasoview Hemopro 2 |
| Astrazeneca Pharmaceuticals LP | $23.87 | 2019 | |
| Cerus Corporation | $23.61 | 2023 | Intercept Blood System For Platelets |
| E.R. Squibb & Sons, L.L.C. | $18.97 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $17.80 | 2019 | |
| Becton, Dickinson and Company | $14.12 | 2019 | |
| Novocure INC. | $12.20 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.